Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy.

[1]  R. Heilig,et al.  An informative polymorphism detectable by polymerase chain reaction at the 3′ end of the dystrophin gene , 1990, Human Genetics.

[2]  L. Tavazzi,et al.  Heart failure-related myopathy. Clinical and pathophysiological insights. , 1999, European heart journal.

[3]  M. Martone,et al.  Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy , 1999, Nature Medicine.

[4]  G. Comi,et al.  Coexistence of mitochondrial DNA and β myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure , 1998, Heart.

[5]  E. Arbustini,et al.  Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. , 1998, The American journal of pathology.

[6]  F. Muntoni,et al.  A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy. , 1998, American journal of human genetics.

[7]  A. Nakamura,et al.  Insertional mutation by transposable element, L1, in the DMD gene results in X-linked dilated cardiomyopathy. , 1998, Human molecular genetics.

[8]  E. Arbustini,et al.  Restrictive cardiomyopathy, atrioventricular block and mild to subclinical myopathy in patients with desmin-immunoreactive material deposits. , 1998, Journal of the American College of Cardiology.

[9]  P. Jongen,et al.  The heart in limb girdle muscular dystrophy , 1998, Heart.

[10]  E. Arbustini,et al.  Recent Advances in Etiopathogenesis of Dilated Cardiomyopathy: Which Relevance for the Clinical Cardiologist? , 1998 .

[11]  K. Campbell,et al.  A 5' dystrophin duplication mutation causes membrane deficiency of alpha-dystroglycan in a family with X-linked cardiomyopathy. , 1997, Journal of molecular and cellular cardiology.

[12]  L. Mestroni,et al.  Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy , 1997, Heart.

[13]  E. Arbustini,et al.  Enteroviral RNA and virus-like particles in the skeletal muscle of patients with idiopathic dilated cardiomyopathy. , 1997, The American journal of cardiology.

[14]  Jason T. Su,et al.  Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. , 1997, Circulation.

[15]  E. Arbustini,et al.  Ten-year experience with endomyocardial biopsy in myocarditis presenting with congestive heart failure: frequency, pathologic characteristics, treatment and follow-up. , 1997, Giornale italiano di cardiologia.

[16]  G. Danieli,et al.  Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. , 1996, Circulation.

[17]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[18]  L. Mestroni,et al.  A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. , 1996, Human molecular genetics.

[19]  E. Arbustini,et al.  Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients. , 1995, American heart journal.

[20]  W. Fogel,et al.  X‐Linked Dilated Cardiomyopathy , 1995 .

[21]  W. Fogel,et al.  X-linked dilated cardiomyopathy. Novel mutation of the dystrophin gene. , 1995, Annals of the New York Academy of Sciences.

[22]  L. Politano,et al.  Mutation of dystrophin gene and cardiomyopathy , 1994, Neuromuscular Disorders.

[23]  E. Arbustini,et al.  Dilated cardiomyopathy requiring cardiac transplantation as initial manifestation of Xp21 Becker type muscular dystrophy , 1994, Neuromuscular Disorders.

[24]  E. Hoffman,et al.  Restoration of half the normal dystrophin sequence in a double-deletion Duchenne muscular dystrophy family. , 1994, American journal of medical genetics.

[25]  F. Muntoni,et al.  Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. , 1993, The New England journal of medicine.

[26]  J. Towbin,et al.  X‐Linked Dilated Cardiomyopathy Molecular Genetic Evidence of Linkage to the Duchenne Muscular Dystrophy (Dystrophin) Gene at the Xp21 Locus , 1993, Circulation.

[27]  C. Doriguzzi,et al.  Dilating cardiomyopathy as the expression of Xp21 Becker type muscular dystrophy , 1992, Journal of the Neurological Sciences.

[28]  E. Arbustini,et al.  H and L ferritins in myocardium in iron overload. , 1991, The American journal of cardiology.

[29]  R. Gibbs,et al.  Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families, using dinucleotide repeat polymorphisms. , 1991, American journal of human genetics.

[30]  R. Heilig,et al.  Nonradioactive assay for new microsatellite polymorphisms at the 5' end of the dystrophin gene, and estimation of intragenic recombination. , 1991, American journal of human genetics.

[31]  Nobelstiftelsen,et al.  Etiology of Human Disease at the DNA Level , 1991 .

[32]  L. Kunkel,et al.  Rapid detection of CA polymorphisms in cloned DNA: application to the 5' region of the dystrophin gene. , 1991, American journal of human genetics.

[33]  R A Gibbs,et al.  Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. , 1988, Nucleic acids research.

[34]  J. Towbin,et al.  X-linked dilated cardiomyopathy. , 1987, The New England journal of medicine.

[35]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[36]  B. Mokri,et al.  Duchenne dystrophy , 1975, Neurology.